Angiodynamics (ANGO) Retained Earnings (2011 - 2026)

Angiodynamics (ANGO) has reported Retained Earnings for 16 consecutive years, with -$465.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings fell 8.56% year-over-year to -$465.9 million; the trailing twelve-month figure through May 2026 stood at -$465.9 million (down 8.56% YoY), and the FY2026 full-year result was -$465.9 million, down 8.56% from the prior year.
• Retained Earnings declined to -$465.9 million in Q2 2026 per ANGO's latest filing, from -$454.5 million in the prior quarter.
• Across five years, Retained Earnings topped out at -$152.1 million in Q1 2022 and bottomed at -$465.9 million in Q2 2026.
• Historically, Retained Earnings has averaged -$315.8 million across 5 years, with a median of -$388.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Retained Earnings gained 3.76% in 2023, then slumped 147.32% in 2024.
• Over 5 years, Retained Earnings stood at -$179.9 million in 2022, then fell by 7.85% to -$194.0 million in 2023, then sank by 115.82% to -$418.7 million in 2024, then slipped by 6.62% to -$446.4 million in 2025, then decreased by 4.37% to -$465.9 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$465.9 million, -$454.5 million, and -$446.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.